Table 2.
Comparison of clinical parameters between 200 patients with and without SARS-CoV2
| SARS-CoV2 (−) (n:115) | SARS-CoV2 (+) (n:85) | p | |
|---|---|---|---|
| Age (years) | 60.4 ± 14.5 | 62.6 ± 12.6 | 0.26 |
| Gender (Female) | 51 (44.3) | 37 (43.5) | 0.91 |
| Coronary artery disease | 26 (22.6) | 41 (48.2) | < 0.001 |
| Chronic obstructive pulmonary disease (COPD) | 3 (2.6) | 6 (7.1) | 0.13 |
| Diabetes Mellitus | 41 (35.7) | 42 (49.4) | 0.05 |
| Hypertension | 52 (45.2) | 49 (57.6) | 0.08 |
| Heart failure | 10 (8.7) | 32 (37.6) | < 0.001 |
| MHD/CAPD | 30 (26.1) | 13 (15.3) | 0.07 |
| Duration of dialysis, (months) | 28 (6 – 291) | 40 (11–240) | 0.002 |
| Mortality | 13 (11.3) | 33 (38.8) | < 0.001 |
p value < 0.05 is significant statistically and was shown as bold
Unless otherwise stated, data were presented as n (%)
Age was presented as mean ± standard deviation, and duration of dialysis as median (min–max)